Connection

Robert Fowler to Hydroxychloroquine

Back to Details
This is a "connection" page, showing publications Robert Fowler has written about Hydroxychloroquine.
Robert Fowler
Connection Strength
0.010
Hydroxychloroquine
  1. Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial. Intensive Care Med. 2021 Aug; 47(8):867-886.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.